Sharon Surrey Barbari is a director of VYNE Therapeutics Inc.
Person profile
Roles
VYNE Therapeutics
Director
Agile Therapeutics
Director
Address
South San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
VYNE Therapeutics Inc.
3 Jan 24
4
VYNE Therapeutics Inc.
15 Dec 23
4
AGILE THERAPEUTICS INC
9 Jun 23
4
VYNE Therapeutics Inc.
12 Aug 22
4
AGILE THERAPEUTICS INC
10 Jun 22
4
VYNE Therapeutics Inc.
20 Jul 21
4
AGILE THERAPEUTICS INC
10 Jun 21
4
Menlo Therapeutics Inc.
21 Aug 20
4
Menlo Therapeutics Inc.
5 Aug 20
4
AGILE THERAPEUTICS INC
11 Jun 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jan 24 | VYNE VYNE Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.33 | 20,000 | 46.60 k | 20,000 |
13 Dec 23 | VYNE VYNE Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.7 | 20,000 | 54.00 k | 20,000 |
8 Jun 23 | AGRX Agile Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 935 | 0.00 | 974 |
8 Jun 23 | AGRX Agile Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 3.58 | 1,065 | 3.81 k | 1,065 |